Title |
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial |
|---|---|
Involved |
Thorsten Götze (Verfasser)
Alexander Reichart (Verfasser) Ulli S. Bankstahl (Verfasser) Claudia Pauligk (Verfasser)
Maria Loose (Verfasser)
Thomas W. Kraus (Verfasser) Moustafa Elshafei (Verfasser) Wolf Otto Bechstein (Verfasser) Jörg Trojan (Verfasser) Matthias Behrend (Verfasser) Nils Homann (Verfasser) Marino Venerito (Verfasser) Wolfram Bohle (Verfasser) Michael Varvenne (Verfasser) Claus Bolling (Verfasser) Dirk M. Behringer (Verfasser) Karsten Kratz-Albers (Verfasser) Gabriele M. Siegler (Verfasser) Wael Hozaeel (Verfasser) Salah-Eddin al- Batran (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Annals of surgical oncology : the official journal of the Society of Surgical Oncology 31, 6, 8.3.2024, date:6.2024, Seite 4073-4083 |
Published |
2024 |
Language |
|
Country |
|
Topic |
|
Subject |
Cancer Therapy. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2407180751168.593781830593 (URN) |
Record ID |
1336100621 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: